For patients with HCC receiving atezo/bev, would you advise any other clinical investigations scheduled during treatment other than basic lab monitoring?
3 Answers
Mednet Member
Medical Oncology · Rutgers Cancer Institute of New Jersey
In the IMBrave 150 study, the most common serious toxicity in the AB arm was GI bleeding. And everyone was required to have their varices both evaluated and treated. It’s not convenient, but get the EGD before starting treatment!
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center
The important pre treatment basic work up, in addition to basic lab monitoring, including labs, urine analysis, TSH, free T4, is to evaluate the clinical need for EGD in patients with cirrhosis and portal HTN as indicated by the study inclusion criteria. Management of varices is up to clinical team ...